Trial Profile
Efficacy of excerise therapy alone and in combination with tiotropium bromide in patients with severe COPD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jan 2011
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 11 Jan 2011 New trial record